Genetic Variations in DNA Methyltransferases and Their Link to Breast Cancer: Findings from a Nested Case-Control Analysis in the Arkansas Rural Community Health Study - Top-Institutions - MDSpire

Genetic Variations in DNA Methyltransferases and Their Link to Breast Cancer: Findings from a Nested Case-Control Analysis in the Arkansas Rural Community Health Study

  • By

  • Sarah A. Mayberry

  • Ping-Ching Hsu

  • Hui-Yi Lin

  • Lora J. Rogers

  • Shelbie D. Stahr

  • L. Joseph Su

  • February 10, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Cancer Epigenetics
    • Genomics

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Molecular Genetics
    • Epigenetics

  • #3

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Cancer Biology
    • Genetics
    • Epigenetics

  • #4

    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

    San Francisco, CA

    Key Differentiators

    • Cancer Epigenetics
    • Genomic Medicine
    • Breast Cancer

  • #5

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Cancer Epidemiology
    • Genomics
    • Epigenetics

Original Source(s)

Genetic Variations in DNA Methyltransferases and Their Link to Breast Cancer: Findings from a Nested Case-Control Analysis in the Arkansas Rural Community Health Study

  • by Sarah A. Mayberry, Ping-Ching Hsu, Hui-Yi Lin, Lora J. Rogers, Shelbie D. Stahr, L. Joseph Su

  • February 10, 2026

Related Content

Management of toxicities from antibody – drug conjugates in breast cancer

Clinician Perspectives on Implementing Breast Cancer–Related Lymphedema Prospective Screening

Clinical implications of 10-formyltetrahydrofolate dehydrogenase expression in hormone receptor-positive breast cancer